Apoptosis in vascular pathology: present and future

Abstract

Apoptosis is recognized as a programmed cell death controlled by genetic mechanisms and required for normal existence of an organism. Its main task is elimination of defective or mutant cells. The particles of dead cells are engulfed by macrophages with no development of inflammatory reaction. Apoptosis actively participates in embryogenesis, cellular homeostasis, elimination of tumor cells, and may be divided to three phases: signal, effector, and degradation. Its main components are cytoplasmic proteases – caspases. Caspases exist in the cytoplasm in inactive condition – in the form pf procaspases. Being activated, they break down to subunits. Proteins of Bcl-2 family are active participants of the mitochondrial pathway of apoptosis. They influence permeability of the outer membrane of mitochondria. Disorders in the mechanisms of apoptosis underlie many diseases including ischemic lesions, autoimmune disorders, malignant neoplasms. The ability to influence survival or death of cell is known to possess enormous therapeutic potential. At present, active research is under way to study signal pathways that control cell cycle and apoptosis. The article discusses the mechanisms participating in death of vascular endothelium and smooth muscle cells, potential role of apoptosis in atherosclerosis is also described.

Keywords

apoptosis / endothelial cells / restenosis / atherosclerotic plaque / smooth muscle cells

References

[1] Egorova IE, Bakhtairova VI, Suslova AI. Molecular mechanisms of apoptosis involved in the development of dif-ferent pathological processes. Innovat-sionnye Tekhnologii v Farmatsii. Irkutsk: ISMU; 2019;6:107-14. (In Russ).

[2] Егорова И.Э., Бахтаирова В.И., Суслова А.И. Молекулярные механизмы апоптоза, вовлеченные в развитие различных патологических процессов. В сб.: Инновационные технологии в фармации. Иркутск: ИГМУ; 2019. Вып. 6. С. 107-114.

[3] Kerr JF, Wyllie AH, Сurrie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. British Journal of Cancer. 1972;26(4):239-57. doi:10.1038/bjc.1972.33

[4] Kerr J.F., Wyllie A.H., Сurrie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics // British Journal of Cancer. 1972. Vol. 26, №4. Р. 239-257. doi:10.1038/bjc.1972.33

[5] Majboroda AA. Apoptosis – genes and proteins. Sibirskij Medicinskij Zurnal (Irkutsk). 2013;118(3): 130-5. (In Russ).

[6] Майборода A.А. Апоптоз – гены и белки // Сибирский медицинский журнал (Иркутск). 2013. Т. 118, №3. С. 130-135.

[7] Varga OYu, Ryabkov VA. Apoptosis: concept, mechanisms of realization, significance. Ekologiya Cheloveka. 2006;(7):28-32. (In Russ).

[8] Варга О.Ю., Рябков В.А. Апоптоз: понятие, механизмы реализации, значение // Экология человека. 2006. №7. С. 28-32.

[9] Yarovaya GA, Neshkova EA, Martynova EA, et al. Rol’ proteoliticheskikh fermentov v kontrole raz-lichnykh stadiy apoptoza. Laboratornaya Medi-tsina. 2011;(11):39-51. (In Russ).

[10] Яровая Г.А., Нешкова Е.А., Мартынова Е.А., и др. Роль протеолитических ферментов в контроле различных стадий апоптоза // Лабораторная медицина. 2011. №11. С. 39-52.

[11] Zhu ZR, He Q, Wu WB, et al. MiR-140-3p is Involved in In-Stent Restenosis by Targeting C-Myb and BCL-2 in Pe-ripheral Artery Disease. Journal of Atherosclerosis and Thrombosis. 2018;25(11): 1168-81. doi:10.5551/jat.44024

[12] Zhu Z.R., He Q., Wu W.B., et al. MiR-140-3p is Involved in In-Stent Restenosis by Targeting C-Myb and BCL-2 in Peripheral Artery Disease // Journal of Atherosclerosis and Thrombosis. 2018. Vol. 25, №11. P. 1168-1181. doi:10.5551/jat.44024

[13] Tsygan VN. Rol’ apoptoza v regulyatsii immunnogo otveta. Obzory po Klinicheskoy Farmakologii i Lekarstvennoy Terapii. 2004;3(2):62-77. (In Russ).

[14] Цыган В.Н. Роль апоптоза в регуляции иммунного ответа // Обзоры по клинической фармакологии и лекар-ственной терапии. 2004. Т. 3, №2. С. 62-77.

[15] Geng YJ. Molecular signal transduction in vascular cell apoptosis. Cell Research. 2001;11(4):253-64. doi:10.1038/sj.cr.7290094

[16] Geng Y.J. Molecular signal transduction in vascular cell apoptosis // Cell Research. 2001. Vol. 11, №4. P. 253-264. doi:10.1038/sj.cr.7290094

[17] Mallat Z, Tedgui A. Apoptosis in the vasculature: mechanisms and functional importance. British Journal of Phar-macology. 2000;130(5):947-62. doi:10.1038/sj.bjp.0703407

[18] Mallat Z., Tedgui A. Apoptosis in the vasculature: mechanisms and functional importance // British Journal of Pharmacology. 2000. Vol. 130, №5. P. 947-962. doi:10.1038/sj.bjp.0703407

[19] Karsan A, Yee E, Poirier GG, et al. Fibroblast growth factor-2 inhibits endothelial cell apoptosis by Bcl-2 dependent and independent mechanisms. The American Journal of Pathology. 1997;151(6): 1775-84.

[20] Karsan A., Yee E., Poirier G.G., et al. Fibroblast growth factor-2 inhibits endothelial cell apoptosis by Bcl-2 dependent and independent mechanisms // The American Journal of Pathology. 1997. Vol. 151, №6. P. 1775-1784.

[21] Fitzgerald TN, Shepherd BR, Asada H. Laminar shear stress stimulates vascular smooth muscle cell apoptosis via the Akt pathway. Journal of Cellular Physiology. 2008;216(2):389-95. doi:10.1002/jcp.21404

[22] Fitzgerald T.N., Shepherd B.R., Asada H., et al. Laminar shear stress stimulates vascular smooth muscle cell apopto-sis via the Akt pathway // Journal of Cellular Physiology. 2008. Vol. 216, №2. P. 389-395. doi:10.1002/jcp.21404

[23] Jagadeeshaa DK, Miller FJ jr, Bhalla RK. Inhibition of Apoptotic Signaling and Neointimal Hyperplasia by Tempol and Nitric Oxide Synthase following Vascular Injury. Journal of Vascular Research. 2009;46(2):109-18. doi:10.1159/000151444

[24] Jagadeeshaa D.K., Miller F.J. jr., Bhalla R.K. Inhibition of Apoptotic Signaling and Neointimal Hyperplasia by Tem-pol and Nitric Oxide Synthase following Vascular Injury // Journal of Vascular Research. 2009. Vol. 46, №2. P. 109-118. doi:10. 1159/000151444

[25] Kalinin RE, Suchkov IA, Mzhavanadze ND, et al. Endothelial Dysfunction In Patients With Cardiac Implantable Electronic Devices (Literature Review). Nauka Molodykh (Eruditio Juvenium). 2016; (3):84-92. (In Russ).

[26] Калинин Р.Е., Сучков И.А., Мжаванадзе Н.Д., и др. Дисфункция эндотелия у пациентов с имплантируемыми сердечно-сосудистыми электронными устройствами (обзор литературы) // Наука молодых (Eruditio Juvenium). 2016. №3. С. 84-92.

[27] Duran X, Vilahur G, Badimon L. Exogenous in vivo NO- donor treatment preserves p53 levels and protects vascular cells from apoptosis. Atherosclerosis. 2009;205(1):101-6. doi:10.1016/j.atheroscle-rosis.2008.11.016

[28] Duran X., Vilahur G., Badimon L. Exogenous in vivo NO- donor treatment preserves p53 levels and protects vascular cells from apoptosis // Atherosclerosis. 2009. Vol. 205, №1. P. 101-106. doi:10.1016/ j.atherosclerosis.2008.11.016

[29] Beohar N, Flaherty JD, Davidson CJ, et al. Anti-restenotic effects of a locally delivered caspases inhibitor in a balloon injury model. Circulation. 2004;109(1):108-13. doi:10.1161/01.CIR.00001057 24.30980.CD

[30] Beohar N., Flaherty J.D., Davidson C.J., et al. Anti-restenotic effects of a locally delivered caspases inhibitor in a bal-loon injury model // Circulation. 2004. Vol. 109, №1. P. 108-113. doi:10.1161/01. CIR.0000105724.30980.CD

[31] Zhurakovsky IP, Bitkhaeva MV, Arkhipov SА, et al. Changes in Bcl-2 protein family expression in the liver and se-rum cytokines level at persisting bacterial infection. Kubanskii Nauchnyi Meditsinskii Vestnik. 2012;(2(131)):84-7. (In Russ).

[32] Жураковский И.П., Битхаева М.В., Архипов С.А., и др. Изменения экспрессии белков семейства bcl-2 в печени крыс и уровень цитокинов в сыворотке крови при персистенции бактериальной инфекции // Кубанский науч-ный медицинский вестник. 2012. №2(131). С. 84-87.

[33] Kutuk O, Basaga Н. Bcl-2 protein family: Implications in vascular apoptosis and atherosclerosis. Apoptosis. 2006;11(10):1661-75. doi:10.1007/s104 95-006-9402-7

[34] Kutuk O., Basaga Н. Bcl-2 protein family: Implications in vascular apoptosis and atherosclerosis // Apoptosis. 2006. Vol. 11, №10. P. 1661-1675. doi:10.1007/s10495-006-9402-7

[35] Pollman MJ, Hall JL, Gibbons G.H. Determinants of vascular smooth muscle cell apoptosis after balloon angioplasty injury: influence of redox state and cell phenotype. Circulation Research. 1999; 84(1):113-21. doi:10.1161/01.res.84.1.113

[36] Pollman M.J., Hall J.L., Gibbons G.H. Determinants of vascular smooth muscle cell apoptosis after balloon angio-plasty injury: influence of redox state and cell phenotype // Circulation Research. 1999. Vol. 84, №1. P. 113-121. doi:10.1161/01.res.84.1.113

[37] Pozhilova EV, Novikov VE. Physiological and pathological value of cellular synthase of nitrogen oxide and endoge-nous nitrogen oxide. Vestnik Smo-lenkskoy Gosudarstvennoy Medicinskoy Akademii. 2015;14(4): 35-41. (In Russ).

[38] Пожилова Е.В., Новиков В.Е. Синтаза оксида азота и эндогенный оксид азота в физиологии и патологии клетки // Вестник Смоленской государственной медицинской академии. 2015. Т. 14, №4. С. 35-41.

[39] Du J, Leng J, Zhang L, et al. Angiotensin II-Induced Apoptosis of Human Umbilical Vein Endothelial Cells was In-hibited by Blueberry Anthocyanin Through Bax- and Caspase 3-Dependent Pathways. Medical Science Monitor. 2016;22:3223-8. doi:10.12659/msm.896916

[40] Du J., Leng J., Zhang L., et al. Angiotensin II-Induced Apoptosis of Human Umbilical Vein Endothelial Cells was Inhibited by Blueberry Anthocyanin Through Bax- and Caspase 3-Dependent Pathways // Medical Science Monitor. 2016. Vol. 22. P. 3223-3228. doi:10.12659/msm.896916

[41] Novitskiy VV, Ryazantseva NV, Starikova EG, et al. Regulyatsiya apoptoza kletok s ispol’zovaniyem gazovykh transmitterov (oksid azota, monooksid ugleroda i sul’fid vodoroda). Vestnik Nauki Sibiri. 2011;1(1):635-40. (In Russ).

[42] Новицкий В.В., Рязанцева Н.В., Старикова Е.Г., и др. Регуляция апоптоза клеток с использованием газовых трансмиттеров (оксид азота, монооксид углерода и сульфид водорода) // Вестник науки Сибири. 2011. №1(1). С. 635-640.

[43] Yang HY, Bian YF, Zhang HP, et al. Angiotensin-(1-7) treatment ameliorates angiotensin II-induced apoptosis of human umbilical vein endothelial cells. Clinical and Experimental Pharmacology & Physio-logy. 2012;39(12):1004-10. doi:10.1111/1440-1681. 12016

[44] Yang H.Y. Bian Y.F., Zhang H.P., et al. Angiotensin-(1-7) treatment ameliorates angiotensin II-indu-ced apoptosis of human umbilical vein endothelial cells // Clinical and Experimental Pharmacology & Physiology. 2012. Vol. 39, №12. P. 1004-1010. doi:10.1111/1440-1681.12016

[45] Jacob T, Hingorani A, Ascher E. p53 gene therapy modulates signal transduction in the apoptotic and cell cycle pathways downregulating neointimal hyperplasia. Vascular and Endovascular Surgery. 2012;46(1):45-53. doi:10.1177/1538574411422277

[46] Jacob T., Hingorani A., Ascher E. p53 gene therapy modulates signal transduction in the apoptotic and cell cycle pathways downregulating neointimal hyperplasia // Vascular and Endovascular Surgery. 2012. Vol. 46, №1. P. 45-53. doi:10.1177/153857 4411422277

[47] Vladimirskaya TE, Shved IA, Demidchik YuE. Ratio of expression of the Bcl-2 and Bax proteins in the atheroscle-rotic coronary artery wall. Proceedings of the National Academy of Sciences of Belarus. Medical Series. 2015;(4):51-5. (In Russ).

[48] Владимирская Т.Э., Швед И.А., Демидчик Ю.Е. Соотношение эксперессии белков BCL-2 b Bax в стенке коро-нарных артерий, пораженных атеросклерозом // Известия национальной академии наук Беларусии. Серия медицинских наук. 2015. №4. С. 51-55.

[49] Parkes JL, Cardell RR, Hubbard FC Jr, et al. Cultured human atherosclerotic plaque smooth muscle cells retain trans-forming potential and display enhanced expression of the myc protooncogene. The American Journal of Pathology. 1991;138(3):765-75.

[50] Parkes J.L., Cardell R.R., Hubbard F.C. Jr., et al. Cultured human atherosclerotic plaque smooth muscle cells retain transforming potential and display enhanced expression of the myc protoonco-gene // The American Journal of Pa-thology. 1991. Vol. 138, №3. P. 765-775.

[51] Tian X, Shi Y, Liu N, et al. Upregulation of DAPK contributes to homocysteine-induced endothelial apoptosis via the modulation of Bcl2/Bax and activation of caspase 3. Molecular Medicine Reports. 2016;14(5):4173-79. doi:10.3892/mmr.2016.5733

[52] Tian X., Shi Y., Liu N., et al Upregulation of DAPK contributes to homocysteine-induced endothelial apoptosis via the modulation of Bcl2/Bax and activation of caspase 3 // Molecular Medicine Reports. 2016. Vol. 14, №5. P. 4173-4179. doi:10. 3892/mmr.2016.5733

[53] Khaspekova SG, Antonova OA, Shustova ON, et al. Tissue factor activity in microparticles produced in vitro by en-dothelial cells, monocytes, granulocytes, and platelets. Biochemistry. 2016;81(2):206-14. (In Russ).

[54] Хаспекова С.Г., Антонова О.А., Шустова О.Н., и др. Активность тканевого фактора в микрочастицах, проду-цируемых in vitro эндотелиальными клетками, моноцитами, гранулоцитами и тромбоцитами // Биохмимия. 2016. Т. 81, №2. С. 206-214.

[55] Рollman MJ, Нall JL, Мann MJ, et al. Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease. Nature Medicine. 1998;4:222-7. doi:10.1038/nm0298-222

[56] Рollman M.J., Нall J.L., Мann M.J., et al. Inhibition of neointimal cell bcl-x expression induces apoptosis and regres-sion of vascular disease // Nature Medicine. 1998. Vol. 4. P. 222-227. doi:10.1038/ nm0298-222

[57] Wang BY, Ho HK, Lin PS, et al. Regression of atherosclerosis: role of nitric oxide and apoptosis. Circulation. 1999;99(9):1236-41. doi:10.1161/01. cir.99.9.1236

[58] Wang B.Y., Ho H.K., Lin P.S., et al. Regression of atherosclerosis: role of nitric oxide and apoptosis // Circulation. 1999. Vol. 99, №9. P. 1236-1241. doi:10.1161/01.cir.99.9.1236

[59] Kalinin RE, Suchkov IА, Pshennikov АS, et al. L-arginine efficiency in treatment for lower limbs arteries atheroscle-rosis and in prevention of reconstruction zone restenosis. Vestnik Ivanovskoy Meditsinskoy Akademii. 2013;18(2):18-21. (In Russ).

[60] Калинин Р.Е., Сучков И.А., Пшенников А.С., и др. Эффективность L-аргинина в лечении атеросклероза арте-рий нижних конечностей и про-филактике рестеноза зоны реконструкции // Вестник Ивановской Медицин-ской Академии. 2013. Т. 18, №2. С. 18-21.

[61] de Araújo Júnior RF, Leitão Oliveira AL, de Melo Silveira RF, et al. Telmisartan induces apoptosis and regulates Bcl-2 in human renal cancer cells. Experimental Biology and Medicine (Maywood NJ). 2015;240(1):34-44. doi:10.1177/1535370214546267

[62] de Araújo Júnior R.F., Leitão Oliveira A.L., de Melo Silveira R.F., et al. Telmisartan induces apoptosis and regulates Bcl-2 in human renal cancer cells // Experimental Biology and Medicine (Maywood N.J.). 2015. Vol. 240, №1. Р. 34-44. doi:10. 1177/1535370214546267

[63] Pshennikov AS, Deev RV. Morphological illustration of alterations in the arterial endothelium in ischemic and reper-fusion injuries. I.P. Pavlov Russian Medical Biological Herald. 2018;26(2):184-94. doi:10.23888/ PAV-LOVJ2018262184-194 (In Russ).

[64] Пшенников А.С., Деев Р.В. Морфологическая иллюстрация изменений артериального эндотелия на фоне ишемического и реперфузионного повреждений // Российский медико-биологичес-кий вестник имени акаде-мика И.П. Павлова. 2018. Т. 26, №2. С. 184-194. doi:10.23888/PAV-LOVJ2018262184-194

[65] Perlman H, Maillard L, Krasinski K, et al. Evidence for the rapid onset of apoptosis in medial smooth muscle cells after balloon injury. Circulation. 1997;95(4):981-7. doi:10.1161/01.cir.95.4.981

[66] Perlman H., Maillard L., Krasinski K., et al. Evidence for the rapid onset of apoptosis in medial smooth muscle cells after balloon injury // Circulation. 1997. Vol. 95, №4. P. 981-987. doi:10.1161/ 01.cir.95.4.981

[67] Isner JM, Kearney M, Bortman S, et al. Apoptosis in human atherosclerosis and restenosis. Circulation. 1995;91(11):2703-11. doi:10.1161/01.cir.91.11.2703

[68] Isner J.M., Kearney M., Bortman S., et al. Apoptosis in human atherosclerosis and restenosis // Circulation. 1995. Vol. 91, №11. P. 2703-2711. doi:10. 1161/01.cir.91.11.2703

[69] Bauriedel G, Schluckebier S, Hutter R, et al. Apoptosis in restenosis versus stable-angina atherosclerosis. Implications for the pathogenesis of restenosis. Ar-teriosclerosis, Thrombosis, and Vascular Biology. 1998;18(7):1132-9. doi:10.1161/01.atv.18.7.1132

[70] Bauriedel G., Schluckebier S., Hutter R., et al. Apoptosis in restenosis versus stable-angina atherosclerosis. Implica-tions for the pathogenesis of restenosis // Arteriosclerosis, Thrombosis, and Vascular Biology. 1998. Vol. 18, №7. P. 1132-1139. doi:10.1161/01.atv.18.7.1132

[71] Shibata R., Kai H., Seki Y., et al. Rho-kinase Inhibition Reduces Neointima Formation After Vascular Injury by En-hancing Bax Expression and Apoptosis. Journal of Cardiovascular Pharmacology. 2003; 42(1):S43-7. doi:10.1097/00005344-200312001-00011

[72] Shibata R., Kai H., Seki Y., et al. Rho-kinase Inhibition Reduces Neointima Formation After Vascular Injury by En-hancing Bax Expression and Apoptosis // Journal of Cardiovascular Pharmacology. 2003. Vol. 42, suppl 1. Р. S43-S47. doi:10.1097/ 00005344-200312001-00011

[73] Krishnan P, Purushothaman KR, Purushothaman M, et al. Histological features of restenosis associated with paclitaxel drug-coated balloon: implications for therapy. Cardiovasc Pathol. 2019;43: 107139. doi:10.1016/j.carpath.2019.06.003

[74] Krishnan P., Purushothaman K.R., Purushothaman M., et al. Histological features of restenosis associated with paclitaxel drug-coated balloon: implications for therapy // Cardiovascular Pathology. 2019. Vol. 43. P. 107139. doi:10.1016/j.carpath.2019. 06.003

RIGHTS & PERMISSIONS

Kalinin R.E., Suchkov I.A., Klimentova Е.A., Egorov A.A., Povarov V.O.